Position paper: The time for cooperative group study of ropeginterferon alfa-2b in young patients with myeloproliferative neoplasms is now.

Kucine, Nicole; Jessup, Jewell A; Cooper, Todd M; Urbanski, Ray W; Kolb, E Anders; Resar, Linda M S

Kucine, Nicole; Jessup, Jewell A; Cooper, Todd M; Urbanski, Ray W; Kolb, E Anders; Resar, Linda M S.

Afiliação

Kucine N; Department of Pediatrics, Weill Cornell Medicine, New York, New York, USA.
Jessup JA; PharmaEssentia is in Burlington MA, PharmaEssentia USA Corporation, Burlington, Massachusetts, USA.
Cooper TM; Cancer and Blood Disorders Center, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA.
Urbanski RW; PharmaEssentia is in Burlington MA, PharmaEssentia USA Corporation, Burlington, Massachusetts, USA.
Kolb EA; The Leukemia & Lymphoma Society, Rye Brook, New York, USA.
Resar LMS; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Pediatr Blood Cancer ; 70(10): e30559, 2023 10.

Article em En | MEDLINE | ID: mdl-37455243

Assuntos

Neoplasias; Polietilenoglicóis; Humanos; Polietilenoglicóis/uso terapêutico; Proteínas Recombinantes/uso terapêutico; Antivirais

Palavras-chave

cancer pharmacology; clinical trials; rare tumors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Neoplasias Limite: Humans Idioma: En Revista: Pediatr Blood Cancer Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google